Tag Archives: Myriad

AMC v. Myriad – “Laws of Nature” Exception Does Not Include Isolated DNA

Posted on July 31, 2011 by Warren Woessner

As noted in my last “flash” post, a divided three-judge Fed. Cir. panel (Judges Lourie, Bryson and Moore) issued an opinion holding that the isolated DNA sequences and the drug-screening method claimed by Myriad are patentable subject matter, not natural … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , , | 2 Comments

Divided Panel Finds DNA Molecules Patentable – Cancer Screening Claims Too Abstract

Posted on July 29, 2011 by Warren Woessner

Today a divided Fed. Cir. panel of Judges Lourie, Moore and Bryson – Lourie writing for the “majority” – reversed the district court judge, in AMP v. Myriad, holding that isolated DNA sequences are patent-eligible subject matter and not natural … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , , | Leave a comment

John L. White Dies – Authored Chemical Patent Practice

Posted on May 11, 2011 by Warren Woessner

I was saddened to hear of the recent passing of John L. White, a founder of the Arlington firm of Millen, White, Zelano & Branigan. Although I did not know him well, he will be remembered for a long, long … Continue reading →

Posted in People | Tagged , , | Leave a comment

Patent System Fosters Eugenics – What Next?

Posted on April 27, 2011 by Warren Woessner

USA TODAY ran a provocative article yesterday (April 26, 2011) on the “dark past” of the respected journal Annals of Human Genetics, in which its editor, Andres Linares did a mea culpa for the role of the journal, founded in … Continue reading →

Posted in Stem Cells/Cloning | Tagged , , , , | Leave a comment